CDS 096370

Drug Profile

CDS 096370

Alternative Names: OSIC 0961370

Latest Information Update: 03 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OSI Pharmaceuticals
  • Developer OSI Pharmaceuticals; Solvay Pharmaceuticals
  • Class
  • Mechanism of Action Adenosine A1 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Renal failure

Most Recent Events

  • 03 Jul 2007 Discontinued - Preclinical for Congestive heart failure in USA (unspecified route)
  • 03 Jul 2007 Discontinued - Preclinical for Renal failure in USA (unspecified route)
  • 31 Jul 2003 OSI Pharmaceuticals intends to focus its business entirely on oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top